Covestor’s Dorman Products DORM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Sell
106
-419
-80% -$49.6K 0.01% 1296
2026
Q1
$55K Sell
525
-225
-30% -$26.8K 0.04% 647
2025
Q4
$93K Sell
750
-178
-19% -$24K 0.05% 613
2025
Q3
$145K Buy
928
+302
+48% +$43.3K 0.08% 355
2025
Q2
$77K Buy
626
+78
+14% +$9.48K 0.05% 699
2025
Q1
$66K Sell
548
-7
-1% -$893 0.04% 717
2024
Q4
$72K Buy
555
+176
+46% +$22.5K 0.05% 699
2024
Q3
$43K Buy
379
+336
+781% +$35.3K 0.03% 926
2024
Q2
$4K Buy
43
+39
+975% +$3.57K ﹤0.01% 1780
2024
Q1
$0 Buy
4
+2
+100% +$172 ﹤0.01% 2330
2023
Q4
$0 Sell
2
-1
-33% -$75 ﹤0.01% 2243
2023
Q3
$0 Buy
3
+1
+50% +$81 ﹤0.01% 2220
2023
Q2
$0 Sell
2
-337
-99% -$28.4K ﹤0.01% 2229
2023
Q1
$29K Buy
339
+58
+21% +$5.17K 0.03% 891
2022
Q4
$23K Buy
281
+119
+73% +$10.1K 0.02% 983
2022
Q3
$13K Buy
162
+157
+3,140% +$15.5K 0.01% 1147
2022
Q2
$1K Sell
5
-2
-29% -$198 ﹤0.01% 1702
2022
Q1
$1K Buy
7
+2
+40% +$194 ﹤0.01% 1777
2021
Q4
$1K Buy
+5
New +$543 ﹤0.01% 1714

Other funds holding DORM

Covestor's DORM Position: Q2 2026 in Review

Covestor reduced its Dorman Products (DORM) stake by 80% in Q2 2026, selling an estimated $49.6K and leaving 106 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #1296.

Covestor first reported a position in DORM in Q4 2021 and has held it in 19 quarters since. The position peaked at $145K in Q3 2025. 328 funds tracked by Wall St. Rank hold DORM as of Q2 2026.

  • Covestor held 106 shares of Dorman Products worth $15K as of Q2 2026.
  • Covestor sold 419 Dorman Products shares in Q2 2026, an estimated $49.6K.
  • Dorman Products made up 0.01% of Covestor's portfolio in Q2 2026, its #1296 holding.
  • Covestor first reported a position in Dorman Products in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Dorman Products position peaked at $145K in Q3 2025.
  • 328 funds tracked by Wall St. Rank held Dorman Products as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.